Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment
CompletedOBSERVATIONAL
Enrollment
164
Participants
Timeline
Start Date
October 20, 2016
Primary Completion Date
October 19, 2017
Study Completion Date
October 19, 2017
Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG
ORALVAC COMPACT BÄUME
Trial Locations (1)
50931
UHCologne, Cologne
All Listed Sponsors
collaborator
Bencard Allergie GmbH
OTHER
lead
University Hospital of Cologne
OTHER
NCT03097432 - Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment | Biotech Hunter | Biotech Hunter